Invitation to Nano2Clinic members to Contribution to Special Issue on “Selective Antitumor Therapy Based on Nanotechnology” in Pharmaceutics

Dr. Rosario M. Sánchez Martín, Guest Editor of a Special Issue of the journal Pharmaceutics entitled “Selective Antitumor Therapy Based on Nanotechnology”, will like to invite our Nano2Clinic members to contribute to this special issue. 

Pharmaceutics has received an updated Impact Factor of 6.321, as published in the 2020 Edition of the Journal Citation Reports® (Clarivate), the 5-Year Impact Factor is 6.734. It now ranks 28/275 (Q1) in  Pharmacology & Pharmacy.


Deadline for submission is * 15 September 2022 *.

 

Please access to the following link for further reading about this special issue:
https://www.mdpi.com/journal/pharmaceutics/special_issues/selective_antitumor

 

Rosario M. Sánchez Martín

Email :rosario.sanchez@genyo.es
 

European Cooperation in Science and Technology (COST) logo
Funded by the European Union